ALEMBIC PHARMA'S ARM GETS USFDA TENTATIVE APPROVAL FOR DRUG TO TREAT PAH

Highlights

• Pulmonary arterial hypertension (PAH) affects arteries in the lungs and in the heart

• As per the reports, this newly approved drug is therapeutically equivalent to the reference listed drug product Remodulin injection which has been developed by United ...